 |
|
Proton Spectroscopy in Myotonic Dystrophy
Correlations With CTG Repeats
Linda Chang, MD;
Thomas Ernst, PhD;
Diane Osborn;
William Seltzer, PhD;
Maria Leonido-Yee, MD;
Russell E. Poland, PhD
Arch Neurol. 1998;55:305-311.
Objectives To seek cerebral metabolite abnormalities in patients with myotonic dystrophy and to determine whether the degree of cerebral abnormalities (measured by proton magnetic resonance spectroscopy) correlates with severity of the genetic defect (measured by trinucleotide repeats).
Design Fourteen patients with myotonic dystrophy were compared with 24 healthy control subjects.
Setting A university-affiliated medical center.
Results Compared with healthy subjects, patients with myotonic dystrophy had elevated levels of myoinositol (+19% in the occipital region and +12.9% in the temporoparietal region), total creatine (+7.6% and +6.8%), and choline-containing compounds (+21% and +7.7%). Furthermore, the creatine and myoinositol peak areas correlated with the number of trinucleotide cytosine-thymine-guaninen (CTG)n repeats from leukocytes, especially in the temporoparietal brain region (r=0.76; P=.004).
Conclusions Neurochemical alterations observed with proton magnetic resonance spectroscopy are proportional to the cytosine-thymine-guanine repeat size. Increases in myoinositol and creatine concentrations may be caused by increased glial content, while elevated levels of choline-containing compounds are most likely caused by increased glial content and cell membrane abnormalities. Proton magnetic resonance spectroscopy is a powerful noninvasive tool to study brain biochemistry, which may reflect the extent of neuropathological involvement in patients with myotonic dystrophy.
From the Departments of Neurology (Drs Chang, Ernst, and Leonido-Yee), Radiology (Dr Ernst and Ms Osborn), and Psychiatry (Dr Poland), Harbor-UCLA Medical Center, Torrance, Calif, and UCLA School of Medicine, Los Angeles, Calif; and Athena Neurosciences Inc, Worcester, Mass (Dr Seltzer).
RELATED ARTICLE
Myotonic Dystrophy as a Brain Disorder
Tetsuo Ashizawa
Arch Neurol. 1998;55(3):291-293.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Effects of Tamoxifen and Estrogen on Brain Metabolism in Elderly Women
Ernst et al.
JNCI J Natl Cancer Inst 2002;94:592-597.
ABSTRACT
| FULL TEXT
Early detection and longitudinal changes in amyotrophic lateral sclerosis by 1H MRSI
Suhy et al.
Neurology 2002;58:773-779.
ABSTRACT
| FULL TEXT
Brain Proton Magnetic Resonance Spectroscopy and Imaging in Children Exposed to Cocaine in Utero
Smith et al.
Pediatrics 2001;107:227-231.
ABSTRACT
| FULL TEXT
1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS
Suhy et al.
Mult Scler 2000;6:148-155.
ABSTRACT
Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia
Lodi et al.
Proc. Natl. Acad. Sci. USA 1999;96:11492-11495.
ABSTRACT
| FULL TEXT
Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy
Meola et al.
Neurology 1999;53:1042-1042.
ABSTRACT
| FULL TEXT
Gender Effects on Persistent Cerebral Metabolite Changes in the Frontal Lobes of Abstinent Cocaine Users
Chang et al.
Am. J. Psychiatry 1999;156:716-722.
ABSTRACT
| FULL TEXT
Brain Proton Magnetic Resonance Spectroscopy and Brain Atrophy in Myotonic Dystrophy
Akiguchi et al.
Arch Neurol 1999;56:325-330.
ABSTRACT
| FULL TEXT
Brain biochemistry in Williams syndrome: Evidence for a role of the cerebellum in cognition?
Chang et al.
Neurology 1999;52:894-894.
FULL TEXT
Myotonic Dystrophy as a Brain Disorder
Ashizawa
Arch Neurol 1998;55:291-293.
FULL TEXT
|
